trending Market Intelligence /marketintelligence/en/news-insights/trending/gxyj6vnxxorkjujkldgjyw2 content esgSubNav
In This List

2 Kadmon Holdings directors resign

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


2 Kadmon Holdings directors resign

Alexandria Forbes and Thomas Shenk are stepping down from the Kadmon Holdings Inc. board.

The directors are resigning to focus on their responsibilities at MeiraGTx Holdings PLC.

New York-based Kadmon Holdings is a biopharmaceutical company developing treatments for inflammatory and fibrotic diseases.